
    
      The purpose of the study for Part 1 is to evaluate the safety and tolerability of PF-06817024
      in healthy subjects.

      The purpose of the study for Part 2 is to evaluate the safety and tolerability of PF-06817024
      in patients with chronic rhinosinusitis with nasal polyps.

      The purpose of the study for Part 3 is to evaluate the safety and tolerability of PF-06817024
      in patients with moderate-to-severe Atopic Dermatitis
    
  